CUBIST PHARMACEUTICALS INC
DelistedCIK 912183fmd_0TTAXQQWYRBAZD4HQA2SP0AGC5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2014, 23 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|---|
| Total revenues | 434 | 562 | 636 | 754 | 926 | 1,054 |
| Cost of revenue | 90 | 117 | 141 | 173 | 230 | 260 |
| Gross profit | 343 | 445 | 496 | 581 | 696 | 794 |
| Realized investment gains (losses) | – | – | 3 | – | – | – |
| Research and development | 127 | 171 | 158 | 185 | 278 | 478 |
| Selling, general and administrative | 126 | 137 | 143 | 163 | 172 | 258 |
| Operating income | 91 | 138 | 190 | 133 | 237 | 26 |
| Interest expense | 21 | 21 | 26 | 31 | 33 | 38 |
| Interest and investment income | 10 | 4 | 5 | 3 | 3 | 2 |
| Other non-operating income (expense) | (61) | (18) | (35) | (28) | (38) | (70) |
| Income before taxes | 30 | 120 | 154 | 105 | 200 | (44) |
| Income tax expense | (98) | 40 | 60 | 72 | 46 | (25) |
| Net income from continuing operations | 128 | 80 | 94 | 33 | 154 | (19) |
| Net income | 128 | 80 | 94 | – | – | – |
| Net income to common shareholders | – | 80 | 94 | 33 | 154 | (19) |